At board meeting held on 13 February 2021 The Board of Nectar Lifescience at its meeting held on 13 February 2021 has appointed Dr. Ajit Singh Dhillon (DIN 09032214) on the Board as an
additional director (independent) of the company till the date of
forthcoming Annual General Meeting in which he can be appointed as a
regular Independent Director.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and upda
On a standalone basis, ABB India s net profit jumped 48.88% to Rs 57.56 crore on 12.93% decrease in total revenue from operations at Rs 1,700.76 crore in Q4 December 2020 over Q4 December 2019.
Profit before tax (PBT) rose 0.53% to Rs 80.39 crore in Q4 December 2020 over Q4 December 2019. Total tax expense for the quarter surged 18.88% to Rs 18.19 crore as against Rs 15.30 crore in Q4 December 2019. The Q4 result was declared during market hours today, 10 February 2021.
The company said it has shown resilient performance as the economy starts to show signs of recovery with strong sequential growth in operating margins. Sequentially, the quarter witnessed uptrend in revenues across all business divisions due to continued focus on execution of order backlog. Factors like export performance, service revenue with system upgrades, sluggish project performance compensated by solid product sales, helped increase revenues during the fourth quarter as compared to the earlier quarter.